NutriBand (NTRB) Shares Outstanding (Weighted Average) (2016 - 2026)
NutriBand's (NTRB) quarterly Shares Outstanding (Weighted Average) came in at $11.6 million in Q1 2026, up 9.74% year-on-year from $10.6 million in Q1 2025, and down 3.45% quarter-over-quarter from $12.1 million in Q4 2025.
NutriBand (NTRB) Shares Outstanding (Weighted Average) (2016 - 2026) Analysis & Trends
NutriBand has disclosed Shares Outstanding (Weighted Average) across 11 years of filings, most recently posting $11.6 million for Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $11.6 million, up 9.74% year-over-year; the trailing twelve-month figure through Jan 2026 was $11.6 million (up 9.74% YoY), and the FY2026 annual result was $11.6 million, up 9.74% from the prior year.
- Shares Outstanding (Weighted Average) came in at $11.6 million for Q1 2026 at NutriBand, down from $12.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $12.1 million in Q4 2025 to a low of $7.8 million in Q4 2022.
- The 5-year median for Shares Outstanding (Weighted Average) is $9.2 million (2024), against an average of $9.5 million.
- Across the five-year window, Shares Outstanding (Weighted Average) surged 1632.85% in 2022 and slipped 14.7% in 2023, its largest moves.
- NutriBand's Shares Outstanding (Weighted Average) stood at $7.8 million in 2022, then grew by 0.38% to $7.8 million in 2023, then jumped by 41.73% to $11.1 million in 2024, then gained by 8.6% to $12.1 million in 2025, then retreated by 3.45% to $11.6 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $11.6 million (Q1 2026), $12.1 million (Q4 2025), and $11.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 185,491.37 Bn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 100.00 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 417.01 Bn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 68.88 Bn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 254.10 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 928.40 Mn |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | 11.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 11.64 Mn |
| Oct 31, 2025 | 12.06 Mn |
| Jul 31, 2025 | 11.22 Mn |
| Apr 30, 2025 | 11.13 Mn |
| Jan 31, 2025 | 10.61 Mn |
| Oct 31, 2024 | 11.10 Mn |
| Jul 31, 2024 | 11.06 Mn |
| Apr 30, 2024 | 9.16 Mn |
| Jan 31, 2024 | 7.95 Mn |
| Oct 31, 2023 | 7.83 Mn |
| Jul 31, 2023 | 7.83 Mn |
| Apr 30, 2023 | 7.83 Mn |
| Jan 31, 2023 | 8.46 Mn |
| Oct 31, 2022 | 7.80 Mn |
| Jul 31, 2022 | 8.78 Mn |
| Apr 30, 2022 | 9.18 Mn |
| Jan 31, 2022 | 7.93 Mn |
| Oct 31, 2021 | 7.59 Mn |
| Jul 31, 2021 | 7.40 Mn |
| Apr 30, 2021 | 6.33 Mn |